Almost from the day I began to use CBCT (Cone Beam Computed Tomography) in my practice, which was back in 2008, I was smitten with Invivo's Anatomage software. When it first hit the market, Anatomage was a truly stunning piece of software. At the time it was probably the most impressive 3D software available.
In the years since, there have been quite a few other companies that have entered the space and there are now some pretty impressive competitors. However, Anatomage has a done a tremendous job of upgrading and improving as well. Even after all these years, Anatomage continues to be one of the best on the market. I continue using it today for a couple of reasons.
The first reason is the imaging aspect as well as my familiarity with it. Anatomage has always provided imaging, filters, features, and tools that give me everything I need to evaluate my cone beam images as well as to virtually treatment plant cases.
The second reason I still love it is the program's interface. Let's face it, a program that provides incredible graphics and tools to enhance those graphics can often be unwieldy. Anatomage has always been intuitive and easy to use. I was impressed with it the first time I saw it... and I continue to be. It has an interface that is easy to understand and the tools are well designed for the end user. I've evaluated a fair number of CBCT reader programs over the years and many have incredible features but are incredibly difficult to use. Not so with Anatomage. The user interface is easy to understand and the program is easy to use.
Now, as it continues to evolve, the company is creating a 3D Dental Division that is is calling Osteoid. Here are the details:
Anatomage, a market leader in medical visualization technology, announced that the company has spun out its 3D dental business as a wholly owned subsidiary called Osteoid. Calvin Hur, an over 20-year veteran of the 3D design and printing industry, will lead Osteoid as its CEO, where he will oversee strategic direction and product roadmap. Anatomage founder and CEO Jack Choi will continue to serve Osteoid as an advisor.
The move will allow each company to focus on expanded innovation in its core specialty. Anatomage will focus on its medical and educational solutions. Osteoid will focus solely on 3D dentistry solutions, including the award-winning Invivo 3D dental imaging solutions, as well as its Invivo Workspace cloud-based platform, and solutions for precision surgical guide fabrication.
Backed by resources from its Anatomage parent, Osteoid will make significant investments in R&D and Go-To-Market initiatives that deliver even more precision and efficiency in visualizing unique anatomy for implant planning, orthodontic, endodontic and prosthodontic applications, and more. Recognizing the pivotal role of key opinion leaders in the dental and supplier ecosystem, Osteoid also will incorporate customer-driven innovation by developing Osteoid’s solutions cooperatively with strategic partners.
With the dental imaging market projected to grow to $4.1 billion by 2025 (Markets and Markets, March 2020), Osteoid is positioned to capture growing demand for digital dental solutions. For over 10 years Osteoid’s Invivo 3D imaging products have served the broad needs of thousands of dental professionals who give these solutions high marks for high quality 3D rendering and design capabilities for restorations, using an intuitive interface and simple workflow. Invivo solutions help visualize anatomy, diagnose, share cases with other professionals and perform fast and intuitive implant planning.
Forthcoming new offerings including Invivo6 Plus for 3D Design, added features for Invivo Workspace, and added capabilities for precision surgical guide production will help dental professionals to become more connected, for even greater precision and efficiency across their businesses.
“Dental practices need technology partners with a total commitment to innovation, so we can continually improve care to patients. As an Invivo software user I’ve found the product to be extremely precise, but more importantly the people behind the company have been incredibly knowledgeable, with a genuine passion for making sure my cases go well,” said Nima S. Massoomi, DMD, MEd, MD, a maxillofacial surgeon and fellowship-trained facial cosmetic surgeon. “Whether as Anatomage or Osteoid, I have appreciated their commitment to our industry, and look forward to following the company,” Dr. Massoomi said.
“Our team is proud to have earned the trust of dental experts for delivering products that streamline the dental workflow,” said Jack Choi, founder and CEO of Anatomage. “As the separate dental-focused entity, Osteoid can remain on the leading edge of 3D visualization technology for the dental industry.”
“Osteoid is on a mission to deliver the future of modern dentistry, and I’m honored to lead such a customer-driven team,” said Calvin Hur, CEO of Osteoid. “We are more focused and committed than ever to helping accelerate the move to digital dentistry.”
For more information on Osteoid’s family of 3D dental imaging solutions visit www.osteoidinc.com.
No comments:
Post a Comment